Printed from Voxsanity (voxsanity.com.au) — NCT05698212 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Endometriosis
Phase 2 Endometriosis Trial, Recruiting
NCT05698212
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are able to understand and agree to participate in the study on your own.
- You were born female and are of childbearing age (meaning you could potentially become pregnant).
- You are between 18 and 50 years old (inclusive).
- You are not pregnant at either of the first two study visits.
- You do not have any overall health conditions or pelvic problems that the study doctor thinks could interfere with the tissue collection or put you at risk.
- You have not had surgery (such as cutting or burning tissue) or received a specific hormone treatment for endometriosis in the past 12 months.
- For Groups 1 and 2: Your doctor suspects you have endometriosis or you have already been diagnosed with it, and your doctor has recommended keyhole (laparoscopic) surgery — or you have had such surgery in the past 12 months for diagnosis purposes only, with no surgical treatment of endometriosis at that time.
- For Group 3: You are not suspected of having endometriosis, have no previous diagnosis or symptoms of it, and have had or are scheduled to have keyhole surgery for another reason (such as a tubal ligation or another abdominal procedure), with no signs of endometriosis found during that surgery.
Who may not be able to join:
- You are younger than 18 or 51 years old or older.
- You have previously had surgery to remove your uterus (hysterectomy).
- You have had surgical treatment or a specific hormone treatment for endometriosis within the past 12 months.
- For Group 3 only: You have previously been diagnosed with endometriosis, or a past surgical report showed signs of endometriosis.
- Your body mass index (BMI) is 40 or above.
- You are currently taking any blood-thinning medication.
- You are currently pregnant, breastfeeding, or have given birth in the last 6 months.
- You have been diagnosed with HIV, AIDS, hepatitis A, B, or C, or currently have any active cancer.
- You have a condition that could make handling the collected tissue samples complicated or unsafe (confirm with trial site).
- You are currently undergoing fertility treatments or hormone therapy.
- You have a history of, or currently have, uterine fibroids.
- You have a history of cancer affecting your reproductive organs.
- You have any condition the study doctor believes would interfere with collecting or analysing tissue samples (confirm with trial site).
- You currently have an active pelvic infection or another infection that would make keyhole surgery unsafe.
- You have taken part in another clinical trial involving an investigational (unapproved) drug or treatment in the past 90 days.
- You have a history of, or suspected, alcohol or illegal drug misuse in the past two years.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.
Contact this trial
Principal Investigator: Sandra M Hurtado, MD, University of Texas Physicians Women's Center
Phone: 855-826-6638
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Phase 2
Sponsor
Hera Biotech, Inc.
Registry
ClinicalTrials.gov
Start date
14 September 2022
Est. completion
25 March 2023
Where this trial is recruiting
🇺🇸 United States
Primary endpoints
Primary Outcome
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.